Evidence mapPaperPMID 27397013Full record

SynthesisDeutsches Arzteblatt international2016

Improving Treatment Adherence in Heart Failure.

Susanne Unverzagt, Gabriele Meyer, Susanne Mittmann, Franziska-Antonia Samos, Malte Unverzagt, Roland Prondzinsky

Registry-linked trialAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Deutsches Arzteblatt international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07185100 (A Prospective, Cross-sectional, Nationwide Community-based Observational Study to Determine the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07185100 recruitingnot on this mapstarted 2025, after this paper: background citation

A Prospective, Cross-sectional, Nationwide Community-based Observational Study to Determine the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR

TypeobservationalSponsorGerman Heart InstituteRan2025 to 2036Enrolled600ConditionsHeart Failure With Preserved Ejection Fraction (HFPEF), Renal Dysfunction, Stage B Heart Failure
3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Interventions for increasing medication adherence in heart failure patients: A narrative review.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Susanne UnverzagtInstitute for Medical Epidemiology, Biostatistics and Informatics, Martin-Luther-University Halle- Wittenberg, Halle (Saale), Institute of Health and Nursing Sciences, Martin-Luther-University Halle- Wittenberg, Halle (Saale), Asklepios Parkklinik Bad Salzungen, Carl-von-Basedow-Klinikum Saalekreis GmbH.
Gabriele Meyer
Susanne Mittmann
Franziska-Antonia Samos
Malte Unverzagt
Roland Prondzinsky

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite improved treatment options, heart failure remains the third most common cause of death in Germany and the most common reason for hospitalization. The treatment recommendations contained in the relevant guidelines have been incompletely applied in practice. The goal of this systematic review is to study the efficacy of adherence-promoting interventions for patients with heart failure with respect to the taking of medications, the implementation of recommended lifestyle changes, and the improvement in clinical endpoints.

methodsWe performed a meta-analysis of pertinent publications retrieved by a systematic literature search.

results55 randomized controlled trials were identified, in which a wide variety of interventions were carried out on heterogeneous patient groups with varying definitions of adherence. These trials included a total of 15 016 patients with heart failure who were cared for as either inpatients or outpatients. The efficacy of interventions to promote adherence to drug treatment was studied in 24 trials; these trials documented improved adherence in 10% of the patients overall (95% confidence interval [CI]: [5; 15]). The efficacy of interventions to promote adherence to lifestyle recommendations was studied in 42 trials; improved adherence was found in 31 trials. Improved adherence to at least one recommendation yielded a long-term absolute reduction in mortality of 2% (95% CI: [0; 4]) and a 10% reduction in the likelihood of hospitalization within 12 months of the start of the intervention (95% CI: [3; 17]).

conclusionMany effective interventions are available that can lead to sustained improvement in patient adherence and in clinical endpoints. Longterm success depends on patients' assuming responsibility for their own health and can be achieved with the aid of coordinated measures such as patient education and regular follow-up contacts.

Indexed as

Drug MonitoringAdultAgedAged, 80 and overCardiotonic AgentsFemaleHealth PromotionHeart FailureHumansInternationalityMaleMiddle AgedPatient Education as TopicPractice Guidelines as TopicPrevalenceQuality Assurance, Health CareCardiotonic Agents

Identifiers

PMID27397013
PMCPMC4941608

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.